Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Etilevodopa
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
PureIMS Prepares for Registration of Levodopa Cyclops DPI for OFF Episodes in Parkinson's
Details : Levodopa Cyclops™ is a levodopa dry powder inhaler which is being evaluated in phase 2 clinical trials for the fast and reliable relief of OFF episodes in Parkinson’s disease.
Brand Name : Levodopa Cyclops
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 18, 2024
Lead Product(s) : Etilevodopa
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Etilevodopa
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Boost-UP Foundation
Deal Size : Undisclosed
Deal Type : Financing
Details : The funds will be used to develop lead program Levodopa Cyclops™ for US and EEA marketing, of which early clinical studies already demonstrated very rapid onset of action in combatting OFF-episodes in Parkinsons' disease.
Brand Name : Levodopa Cyclops
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 03, 2023
Lead Product(s) : Etilevodopa
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Boost-UP Foundation
Deal Size : Undisclosed
Deal Type : Financing
LOOKING FOR A SUPPLIER?